Diagnosis and medical management of ocular surface squamous neoplasia
暂无分享,去创建一个
[1] Madhura G. Joag,et al. Topical 5-Fluorouracil 1% as Primary Treatment for Ocular Surface Squamous Neoplasia. , 2016, Ophthalmology.
[2] G. Nuovo,et al. Human Papilloma Virus Infection Does Not Predict Response to Interferon Therapy in Ocular Surface Squamous Neoplasia. , 2015, Ophthalmology.
[3] L. Asena,et al. Topical Bevacizumab for the Treatment of Ocular Surface Squamous Neoplasia. , 2015, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.
[4] C. Karp,et al. Treatment of Ocular Surface Squamous Neoplasia With Topical Aloe vera Drops , 2015, Cornea.
[5] S. Deng,et al. Topical Interferon Alpha-2b for Treatment of Noninvasive Ocular Surface Squamous Neoplasia with 360° Limbal Involvement , 2014, Journal of ophthalmic & vision research.
[6] C. S. Moon,et al. Surgical versus medical treatment of ocular surface squamous neoplasia: a comparison of recurrences and complications. , 2014, Ophthalmology.
[7] J. Muecke,et al. Long‐term outcomes after adjunctive topical 5‐flurouracil or mitomycin C for the treatment of surgically excised, localized ocular surface squamous neoplasia , 2014, Clinical & experimental ophthalmology.
[8] H. Weiss,et al. Diagnosing Ocular Surface Squamous Neoplasia in East Africa , 2014, Ophthalmology.
[9] Stephen J. Vincent,et al. Risk factors for ocular surface squamous neoplasia recurrence after treatment with topical mitomycin C and interferon alpha-2b. , 2014, American journal of ophthalmology.
[10] D. Stone,et al. Ocular Surface Squamous Neoplasia: A Survey of Changes in the Standard of Care From 2003 to 2012 , 2013, Cornea.
[11] H. Carrara,et al. Identification of ocular surface squamous neoplasia by in vivo staining with methylene blue , 2013, British Journal of Ophthalmology.
[12] I. Rennie,et al. Ocular surface squamous neoplasia: analysis of 78 cases from a UK ocular oncology centre , 2013, British Journal of Ophthalmology.
[13] S. Kase,et al. Expression of αB-crystallin and vascular endothelial growth factor in conjunctival squamous cell carcinoma. , 2013, Anticancer research.
[14] H. Pazarlı,et al. Combined excision, cryotherapy, and intraoperative mitomycin C (EXCRIM) for localized intraepithelial and squamous cell carcinoma of the conjunctiva , 2013, Graefe's Archive for Clinical and Experimental Ophthalmology.
[15] S. Feizi,et al. Subconjunctival Bevacizumab Injection for Ocular Surface Squamous Neoplasia , 2013, Cornea.
[16] Sander R. Dubovy,et al. Diagnosis of ocular surface lesions using ultra-high-resolution optical coherence tomography. , 2013, Ophthalmology.
[17] Sander R. Dubovy,et al. Prevalence, treatment, and outcomes of coexistent ocular surface squamous neoplasia and pterygium. , 2013, Ophthalmology.
[18] Sanket U. Shah,et al. Interferon for Ocular Surface Squamous Neoplasia in 81 Cases: Outcomes Based on the American Joint Committee on Cancer Classification , 2013, Cornea.
[19] D. Stone,et al. Intralesional bevacizumab use for invasive ocular surface squamous neoplasia. , 2012, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.
[20] M. Coroneo,et al. Treatment of conjunctival and corneal epithelial neoplasia with retinoic acid and topical interferon alfa-2b: long-term follow-up. , 2012, Ophthalmology.
[21] Sander R. Dubovy,et al. Clinicopathologic correlation of ocular surface squamous neoplasms at Bascom Palmer Eye Institute: 2001 to 2010. , 2012, Ophthalmology.
[22] C. Abnet,et al. Incidence of squamous-cell carcinoma of the conjunctiva and other eye cancers in the NIH-AARP Diet and Health Study , 2012, Ecancermedicalscience.
[23] Sander R. Dubovy,et al. Predictors of ocular surface squamous neoplasia recurrence after excisional surgery. , 2012, Ophthalmology.
[24] P. Finger,et al. Refractory Squamous Cell Carcinoma of the Conjunctiva Treated With Subconjunctival Ranibizumab (Lucentis): A Two-Year Study , 2012, Ophthalmic plastic and reconstructive surgery.
[25] N. Girolamo. Association of human papilloma virus with pterygia and ocular-surface squamous neoplasia , 2012, Eye.
[26] M. David,et al. Immunomodulatory functions of type I interferons , 2012, Nature Reviews Immunology.
[27] Sander R. Dubovy,et al. Ultra-high resolution optical coherence tomography for differentiation of ocular surface squamous neoplasia and pterygia. , 2011, Ophthalmology.
[28] E. Midena,et al. In vivo confocal microscopy of ocular surface squamous neoplasia , 2011, Eye.
[29] J. Muecke,et al. Adjuvant 5-fluorouracil in the treatment of localised ocular surface squamous neoplasia , 2011, British Journal of Ophthalmology.
[30] K. Goins,et al. Treatment of Ocular Surface Squamous Cell Intraepithelial Neoplasia With and Without Mitomycin C , 2011, Cornea.
[31] A. Galor,et al. Subconjunctival/perilesional recombinant interferon α2b for ocular surface squamous neoplasia: a 10-year review. , 2010, Ophthalmology.
[32] E. Midena,et al. Topical 1% 5-fluorouracil in ocular surface squamous neoplasia: a long-term safety study , 2010, British Journal of Ophthalmology.
[33] A. Galor,et al. Pegylated Interferon Alpha 2b for Treatment of Ocular Surface Squamous Neoplasia: A Pilot Study , 2010, Ocular immunology and inflammation.
[34] A. Al-Barrag,et al. 5-Fluorouracil for the treatment of intraepithelial neoplasia and squamous cell carcinoma of the conjunctiva, and cornea , 2010, Clinical ophthalmology.
[35] D. Lockington,et al. Topical mitomycin C chemotherapy in the management of ocular surface neoplasia: a 10-year review of treatment outcomes and complications , 2010, British Journal of Ophthalmology.
[36] A. Gupta,et al. Treatment of ocular surface squamous neoplasia with Mitomycin C , 2010, British Journal of Ophthalmology.
[37] A. Labbé,et al. [Contribution of in vivo confocal microscopy to diagnosis of invasive ocular surface squamous neoplasia: a case report]. , 2010, Journal francais d'ophtalmologie.
[38] S. Mccormick,et al. The diagnostic value of exfoliative cytology vs histopathology for ocular surface squamous neoplasia. , 2009, American journal of ophthalmology.
[39] J. N. Barros,et al. Long-Term Results of Topical Mitomycin C 0.02% for Primary and Recurrent Conjunctival-Corneal Intraepithelial Neoplasia , 2009, Ophthalmic plastic and reconstructive surgery.
[40] A. Galor,et al. Topical interferon alpha 2b eye-drops for treatment of ocular surface squamous neoplasia: a dose comparison study , 2009, British Journal of Ophthalmology.
[41] P. Finger,et al. Subconjunctival ranibizumab for squamous cell carcinoma of the conjunctiva with corneal extension , 2009, British Journal of Ophthalmology.
[42] W. Feuer,et al. Long-term follow-up of conjunctival and corneal intraepithelial neoplasia treated with topical interferon alfa-2b. , 2008, Ophthalmology.
[43] J. Chodosh,et al. Topical interferon or surgical excision for the management of primary ocular surface squamous neoplasia. , 2008, Ophthalmology.
[44] V. Huerva,et al. Treatment of conjunctival squamous neoplasias with interferon alpha 2ab. , 2008, Journal francais d'ophtalmologie.
[45] L. Hirst. Randomized controlled trial of topical mitomycin C for ocular surface squamous neoplasia: early resolution. , 2007, Ophthalmology.
[46] J. Muecke,et al. Complications of mitomycin C therapy in 100 eyes with ocular surface neoplasia , 2006, British Journal of Ophthalmology.
[47] J. Chodosh,et al. Ocular Surface Squamous Neoplasia: A Standard of Care Survey , 2005, Cornea.
[48] J. Pe’er. Ocular surface squamous neoplasia. , 2005, Ophthalmology clinics of North America.
[49] S. Seregard,et al. Epiphora as a side effect of topical mitomycin C , 2004, British Journal of Ophthalmology.
[50] Michael D. Boehm,et al. Treatment of recurrent corneal and conjunctival intraepithelial neoplasia with topical interferon alfa 2b. , 2004, Ophthalmology.
[51] C. Shields,et al. Clinical survey of 1643 melanocytic and nonmelanocytic conjunctival tumors. , 2004, Ophthalmology.
[52] B. W. Dudney,et al. Limbal stem cell deficiency following topical mitomycin C treatment of conjunctival-corneal intraepithelial neoplasia. , 2004, American journal of ophthalmology.
[53] J. Muecke,et al. Mitomycin C as an adjunct in the treatment of localised ocular surface squamous neoplasia , 2003, The British journal of ophthalmology.
[54] M. Macsai,et al. Ocular surface squamous neoplasia: a review. , 2003, Cornea.
[55] N. Sonenberg,et al. Activation of the p70 S6 Kinase and Phosphorylation of the 4E-BP1 Repressor of mRNA Translation by Type I Interferons* , 2003, Journal of Biological Chemistry.
[56] C. Shields,et al. Topical mitomycin C for extensive, recurrent conjunctival-corneal squamous cell carcinoma. , 2002, American journal of ophthalmology.
[57] J. Pe’er,et al. Topical mitomycin-C for partially excised conjunctival squamous cell carcinoma. , 2002, Ophthalmology.
[58] G. Nuovo,et al. Human papillomavirus 16 and 18 expression in conjunctival intraepithelial neoplasia. , 2002, Ophthalmology.
[59] S. Tseng,et al. Successful Management of Conjunctival Intraepithelial Neoplasia by Interferon α-2b , 2002 .
[60] E. F. Smith,et al. Regression of Presumed Primary Conjunctival and Corneal Intraepithelial Neoplasia With Topical Interferon Alpha-2b , 2002, Cornea.
[61] S. Chatterjee,et al. Preoperative topical and intraoperative local mitomycin C adjuvant therapy in the management of ocular surface neoplasias , 2002, The British journal of ophthalmology.
[62] C. Siganos,et al. The Intraoperative Use of Mitomycin-C in Excision of Ocular Surface Neoplasia With or Without Limbal Autograft Transplantation , 2002, Cornea.
[63] C. Karp,et al. Treatment of conjunctival and corneal intraepithelial neoplasia with topical interferon α-2b , 2001 .
[64] R. Yeatts,et al. 5-Fluorouracil for the treatment of intraepithelial neoplasia of the conjunctiva and cornea. , 2000, Ophthalmology.
[65] P. Boccato,et al. Conjunctival squamous cell carcinoma treated with topical 5-fluorouracil. , 1997, Archives of ophthalmology.
[66] J. Sugar,et al. Mitomycin C treatment for conjunctival-corneal intraepithelial neoplasia: a multicenter experience. , 1997, Ophthalmology.
[67] J. Darnell. STATs and gene regulation. , 1997, Science.
[68] M. Wilson,et al. Topical mitomycin C for the treatment of conjunctival and corneal epithelial dysplasia and neoplasia. , 1997, American journal of ophthalmology.
[69] C. Shields,et al. Surgical management of conjunctival tumors. The 1994 Lynn B. McMahan Lecture. , 1997, Archives of ophthalmology.
[70] G. Snibson,et al. Late recurrences and the necessity for long-term follow-up in corneal and conjunctival intraepithelial neoplasia. , 1997, Ophthalmology.
[71] J. Goedert,et al. Epidemiology of squamous cell conjunctival cancer. , 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[72] S. Lewallen,et al. Carcinoma of the conjunctiva and HIV infection in Uganda and Malawi. , 1996, The British journal of ophthalmology.
[73] V. Beral,et al. Effect of ambient solar ultraviolet radiation on incidence of squamous-cell carcinoma of the eye , 1996, The Lancet.
[74] I. Scott,et al. Conjunctival intraepithelial neoplasia : A possible marker for human immunodeficiency virus infection ? , 1996 .
[75] S. L. Maskin. Regression of limbal epithelial dysplasia with topical interferon. , 1994, Archives of ophthalmology.
[76] A. Green,et al. Risk factors in the development of ocular surface epithelial dysplasia. , 1994, Ophthalmology.
[77] L. Hirst,et al. Incidence of ocular surface epithelial dysplasia in metropolitan Brisbane. A 10-year survey. , 1992, Archives of ophthalmology.
[78] R. Keizer,et al. Topical application of 5-Fluorouracil in premalignant lesions of cornea, conjunctiva and eyelid , 1986, Documenta Ophthalmologica.
[79] J. Erie,et al. Conjunctival and corneal intraepithelial and invasive neoplasia. , 1986, Ophthalmology.
[80] D. Gaasterland,et al. Ocular involvement in xeroderma pigmentosum. , 1982, Ophthalmology.
[81] J. A. Burns,et al. Punctal-canalicular stenosis related to systemic fluorouracil therapy. , 1981, Archives of ophthalmology.
[82] K. Cantell,et al. Synthesis in E. coli of a polypeptide with human leukocyte interferon activity , 1980, Nature.
[83] J. Muecke,et al. Management of diffuse ocular surface squamous neoplasia: efficacy and complications of topical chemotherapy , 2015, Clinical & experimental ophthalmology.
[84] Benjamin J. Thomas,et al. Ultra high-resolution anterior segment optical coherence tomography in the diagnosis and management of ocular surface squamous neoplasia. , 2014, The ocular surface.
[85] R. Casson,et al. The Clinical Applications of Fluorouracil in Ophthalmic Practice , 2012, Drugs.
[86] A. Eggermont,et al. Redefining the role of interferon in the treatment of malignant diseases. , 2010, European journal of cancer.
[87] L. Zografos,et al. Topical retinoic acid in dysplastic and metaplastic keratinization of corneoconjunctival epithelium , 2005, Graefe's Archive for Clinical and Experimental Ophthalmology.
[88] M. Uiprasertkul,et al. Topical 0.002% mitomycin C for the treatment of conjunctival-corneal intraepithelial neoplasia and squamous cell carcinoma. , 2005, Cornea.
[89] C. Shields,et al. Chemoreduction with topical mitomycin C prior to resection of extensive squamous cell carcinoma of the conjunctiva. , 2005, Archives of ophthalmology.
[90] S. Tseng,et al. Successful management of conjunctival intraepithelial neoplasia by interferon alpha-2b. , 2002, Japanese journal of ophthalmology.
[91] C. Karp,et al. Treatment of conjunctival and corneal intraepithelial neoplasia with topical interferon alpha-2b. , 2001, Ophthalmology.
[92] C. Karp,et al. Perilesional and topical interferon alfa-2b for conjunctival and corneal neoplasia. , 1999, Ophthalmology.
[93] F. Hu,et al. Interferon treatment for corneolimbal squamous dysplasia. , 1998, American journal of ophthalmology.